Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haldol vs Metoclopramide for Acute Migraine
NCT02098499Phase 4Withdrawn
- Sponsor
- Naval Medical Center Portsmouth
- Start
- Jun 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of haloperidol in migraine, sponsored by Naval Medical Center Portsmouth. Planned start Jun 2013; status: withdrawn.
02
Drugs
haloperidol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02098499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098499.